reports hero background
UPDATED: Nov 20, 2025

Stock Analysis

BAK Logo
Braskem
NYSE:BAK
$3.04
-$0.05 |-1.62%
Day Range:
$3.02 - $3.25
Market Cap:
1.22B
P/E Ratio:
0.0000
Avg Value:
$3.89
Year Range:
$2.32 - $5.46
1
General Information
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico.

It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

2
Braskem (BAK) Stock Graph
3
How We Grade Braskem (BAK)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Braskem (BAK) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

4.79

Growth measures a stock's combined historical expansion in earnings and revenue across multiple time periods, with emphasis on both long-term trends and recent performance.

Momentum measures a stock's relative strength based on its price movement patterns and volatility over multiple timeframes, ranked as a percentile against other stocks.

Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
5
Peer Ratings

See how Braskem compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
PCTPureCycle Technologies
0
0
29.08
24.65
MATVMativ Holdings
0
0
11
89.17
WLKPWestlake Chemical
84.82
33.22
19.37
16.62
KOPKoppers Holdings
71.52
30.32
20.98
19.25
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
6
Financial Health
What is the current state of the company's financial situation?

We measure the health of a company based on how profitable they are and their ability to cover both their short-term and long-term debts. The key indicators that we use are the Operating Margin, Quick Ratio, and Debt-to-Equity ratio relative to the companies peers

Operational Margin -0.0461

The operating margin measures how much profit a company makes after it spends money on wages, materials or other administrative expenses but before interest and taxes. It is a good representation of how efficiently a company is able to generate profit from its core operations.

Quick Ratio 0.5979

The quick ratio measures how much of a company's debt, that is due in less than 1 year, can be covered using its cash equivalents, marketable securities, and money that is currently owed to them (accounts receivables).

A company with a quick ratio of less than 1.00 does not, in many cases, have the capital on hand to meet its short-term obligations if they were all due at once, while a quick ratio greater than one indicates the company has the financial resources to remain solvent in the short term.

Debt-to-Equity -25.6315

Debt-to-equity is calculated by dividing a company's total liabilities by its shareholders equity. It is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. Generally speaking, a D/E ratio below 1.0 would be seen as relatively safe, whereas ratios of 2.0 or higher would be considered risky.

The chart above shows Braskem (BAK) operating margin, quick ratio, and debt-to-equity ratio compared to its peers. The black markers represent the peer averages for each ratio and the blue bars represent Braskem (BAK) ratio values.
7
Past Performance
How has Braskem (BAK) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

Braskem (BAK) sharpe ratio over the past 5 years is -0.5638 which is considered to be below average compared to the peer average of -0.4669

8
Company Financials
INCOME STATEMENT
The income statement also known as the profit and loss statement, primarily focuses on the company's revenues and expenses during a particular period.

The main purpose of an income statement is to convey details of profitability and business activities. Below, is BAK's income statement for the previous four years along with its trailing-twelve- month profit & loss.

FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Total Revenue
105.62
96.52
70.57
77.41
73.77
Operating Revenue
105.62
96.52
70.57
77.41
73.77
Cost Of Revenue
73.57
85.16
67.55
71.41
70.51
Gross Profit
32.06
11.36
3.02
6.00
3.25
Operating Expense
5.74
6.94
5.52
5.09
4.01
Selling General And Administration
4.58
4.87
4.39
4.63
4.82
Research and Development
0.30
0.37
0.38
0.46
0.50
Operating Income
26.32
4.43
-2.49
0.90
-0.75
Net Non-Operating Interest Income Expense
-4.08
-3.65
-3.91
-5.13
-5.62
Other Income Expense
-4.27
-0.72
0.22
-13.50
-4.26
Other Non-Operating Income Expenses
0.00
0.00
0.00
-2.07
-3.23
Pre-Tax Income
17.96
0.05
-6.19
-17.73
-10.63
Tax Provision
4.00
0.87
-1.30
-5.68
-4.82
Net Income
13.99
-0.34
-4.58
-11.32
-5.24
Net Income Common Stockholders
13.99
-0.34
-4.58
-11.32
-5.24
Total Operating Income As Reported
0.00
0.00
0.00
0.00
0.00
Total Expenses
79.31
92.10
73.06
76.51
74.52
Net Income From Continuing And Discontinued Operation
13.99
-0.34
-4.58
-11.32
-5.24
Normalized Income
16.82
0.16
-4.60
-3.61
-4.69
Interest Income
1.83
1.67
1.08
1.26
0.99
Interest Expense
5.91
4.90
3.05
5.44
6.13
Net Interest Income
-4.08
-3.65
-3.91
-5.13
-5.62
EBIT
23.87
4.95
-3.15
-12.29
-4.50
EBITDA
28.05
9.68
2.06
-7.35
0.15
Reconciled Cost Of Revenue
73.57
85.16
67.55
71.41
70.51
Reconciled Depreciation
4.18
4.73
5.21
4.95
4.65
Normalized EBITDA
32.30
10.34
1.70
4.07
1.17
Tax Rate For Calcs
0.00
0.00
0.00
0.00
0.34
Tax Effect Of Unusual Items
-1.41
-0.16
0.34
-3.70
-0.47
BALANCE SHEET
The balance sheet is a snapshot of a companies financials during a particular period in time.

It breaks down what company owns (assets) and what a company owes (liabilities), in order to give investors an overview of its capital structure.

FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Total Assets
92.56
88.05
91.74
101.58
87.38
Current Assets
39.29
34.46
37.44
37.04
26.27
Total Non-Current Assets
53.27
53.59
54.30
64.54
61.11
Total Liabilities Net Minority Interest
86.36
81.94
88.46
105.85
90.56
Current Liabilities
25.19
24.19
24.49
28.27
22.35
Other Non-Current Liabilities
0.77
0.51
0.00
0.39
0.00
Total Equity Gross Minority Interest
6.20
6.11
3.28
-4.28
-3.17
Stockholders Equity
0.00
0.00
0.00
0.00
0.00
Total Capitalization
57.43
54.66
57.20
61.50
53.62
Common Stock Equity
7.87
7.32
3.99
-4.78
-3.53
Net Tangible Assets
4.99
4.30
0.88
-8.17
-6.57
Working Capital
14.10
10.27
12.95
8.77
3.92
Invested Capital
58.92
56.91
59.97
64.63
55.68
Tangible Book Value
4.99
4.30
0.88
-8.17
-6.57
Total Debt
54.21
53.83
59.91
73.72
63.24
Net Debt
42.37
37.12
41.79
54.43
52.55
Share Issued
0.80
0.80
0.80
0.80
0.80
Ordinary Shares Number
0.80
0.80
0.80
0.80
0.80
CASH FLOW STATEMENTS
A companies statement of cash flows gives an investor a break down of the cash inflows and outflows from a companies operations and investment activities.
FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Cash Flow from Continuing Operating Activities
14.72
8.95
-2.28
2.44
-2.89
Net Income from Continuing Operations
17.96
0.05
-6.19
-17.73
-10.63
Depreciation and Amortization
4.73
4.65
Deferred Tax
-1.03
Deferred Income Tax
-1.03
Stock-Based Compensation
Other Non-Cash Items
6.38
2.71
2.69
17.55
7.22
Change in Working Capital
-9.39
3.97
-1.94
0.56
-0.90
Change in Receivables
2.57
4.67
0.14
0.61
-0.08
Changes in Account Receivables
-2.18
3.66
0.07
0.31
Change in Inventory
-7.57
2.14
1.81
-0.18
1.27
Change in Payables and Accrued Expense
-2.10
-0.86
1.55
-0.46
-0.79
Change in Payable
-2.10
-0.86
1.55
-0.46
-0.79
Change in Account Payable
0.87
0.25
1.95
0.38
-1.19
Change in Other Current Assets
0.30
1.53
-2.28
3.33
1.78
Change in Other Current Liabilities
-0.39
-0.32
Change in Other Working Capital
-2.21
-3.18
-3.16
-2.63
-2.98
Cash Flow from Continuing Investing Activities
-4.20
-4.95
-4.21
-3.48
-3.35
Net PPE Purchase and Sale
-3.38
-4.85
-4.46
-3.71
-3.60
Net Business Purchase and Sale
-0.11
-0.08
Purchase of Business
-0.11
-0.08
Net Investment Purchase and Sale
Purchase of Investment
Sale of Investment
Net Other Investing Changes
Financing Cash Flow
-16.97
0.22
8.56
0.47
0.42
Cash Flow from Continuing Financing Activities
-16.97
0.20
8.56
0.47
0.42
Net Issuance Payments of Debt
-10.97
1.59
8.28
0.44
0.44
Net Long-Term Debt Issuance
-1.58
-0.98
8.28
0.14
-1.22
Long-Term Debt Issuance
12.22
7.03
6.89
Long-Term Debt Payments
-8.85
-0.98
-3.94
-6.40
-7.43
Net Short-Term Debt Issuance
-9.40
2.56
Net Common Stock Issuance
Common Stock Issuance
Common Stock Payments
Cash Dividends Paid
-5.99
-1.35
-0.01
-0.01
Net Other Financing Charges
-0.01
0.28
-0.02
End Cash Position
42.97
43.85
53.45
55.33
42.15
Changes in Cash
-5.56
4.23
2.08
-0.58
-5.41
Beginning Cash Position
48.15
40.06
51.73
54.53
47.41
Capital Expenditure
-3.42
-4.85
-4.53
-3.76
-3.60
Issuance of Capital Stock
Issuance of Debt
6.42
12.22
6.71
6.17
Repayment of Debt
-18.27
-4.83
-3.94
-5.79
-5.05
Repurchase of Capital Stock
Free Cash Flow
11.37
4.10
-6.80
-1.33
-6.09